RT @dradityabardia: @HannahAlison20 @ArielleMedford @TumorBoardTues @MPishvaian @JohnEbbenMDPhD @FDA Efficacy seen in both somatic BRCA and…
RT @HannahAlison20: This 👇 #PALB2 your day will come when the world knows your name too. #TumorBoardTuesday
This 👇 #PALB2 your day will come when the world knows your name too. #TumorBoardTuesday
RT @dradityabardia: @HannahAlison20 @ArielleMedford @TumorBoardTues @MPishvaian @JohnEbbenMDPhD @FDA Efficacy seen in both somatic BRCA and…
@HannahAlison20 @ArielleMedford @TumorBoardTues @MPishvaian @JohnEbbenMDPhD @FDA Efficacy seen in both somatic BRCA and gPALB2 (latter quite impressive): https://t.co/FIHCrjdLwj https://t.co/Sfk8EQXqnp
Identification of Somatically Acquired https://t.co/oF6H7INT2i
Identification of Somatically Acquired https://t.co/oF6H7INT2i
Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer https://t.co/85KcFQxRRS
Identification of Somatically Acquired https://t.co/oF6H7INT2i
Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer https://t.co/yfDdGf07mo
Identification of somatically acquired BRCA1/2 mutations by cfDNA analysis in patients with metastatic breast cancer. https://t.co/oF6H7INT2i
RT @NatRevClinOncol: Somatic BRCA1/2 mutations are readily detectable in cfDNA from patients with metastatic #breastcancer, and can be pres…
Identificación de mutaciones de #BRCA1/2 adquiridas somáticamente por análisis de #ADNc en pacientes con #CáncerdeMama #Metastásico https://t.co/UHhYqY9PLB https://t.co/0jLCpSMPqE
CfDNA= circulating free DNA.
Somatic BRCA1/2 mutations are readily detectable in cfDNA from patients with metastatic #breastcancer, and can be present as both known germline-pathogenic and novel variants: https://t.co/x48dRUUubw #bcsm
Identification of somatically acquired BRCA1/2 mutations by cfDNA analysis in patients with metastatic breast cancer. https://t.co/oF6H7INT2i
PubMed_ Identification of somatically acquired BRCA1/2 mutations by cfDNA analysis in patients with metastatic breast cancer. https://t.co/8km4bpGDrR
RT @m0370: 当然出てくると思ったけどsBRCAもcfDNAで判定する流れ。まあそうなりますよねー。 /Clin Cancer Res https://t.co/HNsYr9Yvbc
当然出てくると思ったけどsBRCAもcfDNAで判定する流れ。まあそうなりますよねー。 /Clin Cancer Res https://t.co/HNsYr9Yvbc